Afrezza Interactions
There are 411 drugs known to interact with Afrezza (insulin inhalation, rapid acting), along with 6 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 15 are major, 375 are moderate, and 21 are minor.
- View all 411 medications that may interact with Afrezza
- View Afrezza alcohol/food interactions (1)
- View Afrezza disease interactions (6)
Most frequently checked interactions
View interaction reports for Afrezza (insulin inhalation, rapid acting) and the medicines listed below.
- albuterol
- allopurinol
- amlodipine
- aspirin
- atorvastatin
- Belsomra (suvorexant)
- Bydureon (exenatide)
- carvedilol
- citalopram
- clonidine
- Creon (pancrelipase)
- Crestor (rosuvastatin)
- Cymbalta (duloxetine)
- doxazosin
- Farxiga (dapagliflozin)
- ferrous sulfate
- fluticasone nasal
- gabapentin
- Humalog (insulin lispro)
- Humalog KwikPen (insulin lispro)
- hydrochlorothiazide
- Januvia (sitagliptin)
- levothyroxine
- Linzess (linaclotide)
- melatonin
- meloxicam
- metformin
- Tresiba (insulin degludec)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Afrezza alcohol/food interactions
There is 1 alcohol/food interaction with Afrezza (insulin inhalation, rapid acting).
Afrezza disease interactions
There are 6 disease interactions with Afrezza (insulin inhalation, rapid acting) which include:
More about Afrezza (insulin inhalation, rapid acting)
- Afrezza consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (37)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: insulin
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.